QSAM Biosciences, Inc. Quarterly report pursuant to Section 13 or 15(d)

STOCK OPTIONS (Tables)

9 Months Ended

Sep. 30, 2022

Vesting Description	Number of Options

		87,500
50% 12 months after issuance and the balance 24 months after issuance		87,500
100% 10 months after issuance		25,000
34% 12 months after issuance, 33% 24 months after issuance, and the remaining 36 months after issuance		25,000
Performance conditions set by Board of Directors		12,500

A summary of stock option activity and related information is as follows:

SUMMARY OF STOCK OPTION ACTIVITY

	Options		Weighted Average Exercise Price		Weighted Average Remaining Contractual Term in Years		Aggregate Intrinsic Value
Outstanding as of December 31, 2021		27,815	$	30.46		7.90	$	-
Granted		150,000	$	9.25		10.00	$	-
Outstanding as of September 30, 2022		177,815	$	12.57		9.06	$	-
Exercisable as of September 30, 2022		30,315	$	37.00		7.16	$	-

The assumptions that were used in Black-Scholes option pricing model for the nine months ended September 30, 2022 were as follows: